Leonteq Securities’s Nektar Therapeutics NKTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$242K Sell
4,000
-400
-9% -$28.1K 0.01% 463
2026
Q2
$307K Buy
4,400
+2,400
+120% +$176K 0.01% 493
2026
Q1
$144K Sell
2,000
-6,000
-75% -$342K 0.01% 662
2025
Q4
$338K Buy
+8,000
New +$448K 0.01% 548

Other funds holding NKTR

Leonteq Securities's NKTR Position: Q3 2026 in Review

Leonteq Securities reduced its Nektar Therapeutics (NKTR) stake by 9.1% in Q3 2026, selling an estimated $28.1K and leaving 4,000 shares worth $242K. The position accounts for 0.01% of the portfolio, ranked #463.

Leonteq Securities first reported a position in NKTR in Q4 2025 and has held it in 4 quarters since. The position peaked at $338K in Q4 2025. 240 funds tracked by Wall St. Rank hold NKTR as of Q3 2026.

  • Leonteq Securities held 4,000 shares of Nektar Therapeutics worth $242K as of Q3 2026.
  • Leonteq Securities sold 400 Nektar Therapeutics shares in Q3 2026, an estimated $28.1K.
  • Nektar Therapeutics made up 0.01% of Leonteq Securities's portfolio in Q3 2026, its #463 holding.
  • Leonteq Securities first reported a position in Nektar Therapeutics in Q4 2025 and has held it in 4 quarters since.
  • Leonteq Securities's Nektar Therapeutics position peaked at $338K in Q4 2025.
  • 240 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q3 2026.

Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.